Cargando…

The Influence of Overweight and Obesity on Treatment Response in Juvenile Idiopathic Arthritis

Background: There is evidence that obesity could be a risk factor for the severity and response to treatment in adult patients with rheumatoid arthritis (RA) due both to the mechanical effect of overweight and to the potential pro-inflammatory effects of cytokines produced by adipose tissue. Objecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giani, Teresa, De Masi, Salvatore, Maccora, Ilaria, Tirelli, Francesca, Simonini, Gabriele, Falconi, Martina, Cimaz, Rolando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582667/ https://www.ncbi.nlm.nih.gov/pubmed/31249526 http://dx.doi.org/10.3389/fphar.2019.00637

Ejemplares similares

Localized scleroderma in a cohort of juvenile idiopathic arthritis children
por: Giani, Teresa, et al.
Publicado: (2014)

Serum Amyloid A Circulating Levels and Disease Activity in Patients with Juvenile Idiopathic Arthritis
por: Cantarini, Luca, et al.
Publicado: (2012)

Psoriatic Juvenile Idiopathic Arthritis Associated with Uveitis: A Case Report
por: Moretti, Davide, et al.
Publicado: (2013)

In vitro effects of etanercept on the development of different T cell subsets in patients with juvenile idiopathic arthritis
por: Cimaz, Rolando, et al.
Publicado: (2011)

Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status
por: Di Paola, Monica, et al.
Publicado: (2016)

A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis
por: Rusche, Hendrik, et al.
Publicado: (2021)

Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis
por: Cantarini, L, et al.
Publicado: (2011)

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
por: Sota, Jurgen, et al.
Publicado: (2019)

Moving from nature to nurture: a systematic review and meta-analysis of environmental factors associated with juvenile idiopathic arthritis
por: Clarke, Sarah L N, et al.
Publicado: (2021)

Genetic determinants for methotrexate response in juvenile idiopathic arthritis
por: Pastore, Serena, et al.
Publicado: (2015)

IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis
por: Giancane, Gabriella, et al.
Publicado: (2016)

Usefulness of MRI in the follow-up of ERA-related sacroiliitis, and effectiveness of treatment with sulphasalazine
por: Pagnini, Ilaria, et al.
Publicado: (2011)

Sensorineural hearing loss: a new manifestation of neonatal lupus erythematosus?
por: Pagnini, Ilaria, et al.
Publicado: (2014)

Periodic fever syndromes and the autoinflammatory diseases (AIDs)
por: Marino, Achille, et al.
Publicado: (2019)

Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA)
por: Falcini, FF, et al.
Publicado: (2008)

Current Medical Treatments for Juvenile Idiopathic Arthritis
por: Ruperto, Nicolino, et al.
Publicado: (2011)

Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members
por: Marino, Achille, et al.
Publicado: (2020)

Septic Arthritis and Related Conditions
por: Giani, Teresa, et al.
Publicado: (2022)

Th17 and Th1 Lymphocytes in Oligoarticular Juvenile Idiopathic Arthritis
por: Maggi, Laura, et al.
Publicado: (2019)

Increased Immunity against the Oral Germs Porphyromonas gingivalis and Prevotella intermedia in Different Categories of Juvenile Idiopathic Arthritis
por: Zekre, Franck, et al.
Publicado: (2022)

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease
por: Sota, Jurgen, et al.
Publicado: (2019)

Biomarkers of Response to Biologic Therapy in Juvenile Idiopathic Arthritis
por: Choida, Varvara, et al.
Publicado: (2021)

Kawasaki shock syndrome: a case report
por: Marrani, Edoardo, et al.
Publicado: (2014)

The intestinal microbiota in enthesitis-related arthitis
por: Paladini, Alessia, et al.
Publicado: (2014)

“Brucellupus” in a boy: challenging sle diagnosis in childhood
por: Paganelli, Valeria, et al.
Publicado: (2014)

Concomitant Use of Elexacaftor/Tezacaftor/Ivacaftor and Etanercept in a Cystic Fibrosis Patient with Juvenile Idiopathic Arthritis
por: Orsini, Sara Immacolata, et al.
Publicado: (2023)

PReS-FINAL-2013: Sodium thiosulfate for the treatment of Juvenile Dermatomyositis complicated by calcinosis
por: Pagnini, I, et al.
Publicado: (2013)

Acute Arthritis in Children: How to Discern between Septic and Non-Septic Arthritis?
por: Gamalero, Lisa, et al.
Publicado: (2021)

Cutaneous PAN and Common Variable Immunodeficiency: what causes what?
por: Pagnini, Ilaria, et al.
Publicado: (2011)

Pregnancy in juvenile idiopathic arthritis: maternal and foetal outcome, and impact on disease activity
por: Gerosa, Maria, et al.
Publicado: (2022)

Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting
por: Ferrara, Giovanna, et al.
Publicado: (2018)

FOXP3 expression in peripheral blood and synovial cells of patients with juvenile idiopathic arthritis: relationship with IL-17 at cytokine and molecular level
por: Olivito, B, et al.
Publicado: (2008)

Course, outcome and complications in a single centre cohort of 53 indian children with systemic onset juvenile idiopathic arthritis with a minimum follow up of 3 years
por: Dewoolkar, Mansi, et al.
Publicado: (2014)

Early Prediction of Clinical Response to Etanercept Treatment in Juvenile Idiopathic Arthritis Using Machine Learning
por: Mo, Xiaolan, et al.
Publicado: (2020)

Collaboration in long term follow-up of juvenile idiopathic arthritis
por: Larbre, JP, et al.
Publicado: (2008)

Obesity and disease activity in juvenile idiopathic arthritis
por: Pelajo, Christina F, et al.
Publicado: (2012)

Clinical Use and Molecular Action of Corticosteroids in the Pediatric Age
por: Ferrara, Giovanna, et al.
Publicado: (2019)

Early and Accurate Prediction of Clinical Response to Methotrexate Treatment in Juvenile Idiopathic Arthritis Using Machine Learning
por: Mo, Xiaolan, et al.
Publicado: (2019)

Metabolomic Profiling Identifies Exogenous and Microbiota-Derived Metabolites as Markers of Methotrexate Efficacy in Juvenile Idiopathic Arthritis
por: Funk, Ryan Sol, et al.
Publicado: (2021)

Juvenile idiopathic arthritis in Harlequin ichthyosis, a rare combination or the clinical spectrum of the disease? Report of a child treated with etanercept and review of the literature
por: Baldo, Francesco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n4k1g1atskn6bhqarvgpct3rne